Induced Pluripotent Stem Cells Industry Poised For 9.1% CAGR Growth By 2028

(MENAFN- GlobeNewsWire - Nasdaq) Revolutionizing disease Modeling and Medicine: The Ethical and Versatile Potential of Induced Pluripotent Stem Cells (iPSCs)

Boston, Jan. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research,“ Induced Pluripotent Stem Cells: Global Markets is expected to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

The report analyzes application types, product functions, iPSC generation, and types of iPSC-derived cells and species. Application segments include drug development, toxicity testing, academic research, and regenerative medicine. Product function segments cover molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation, and cell analysis. iPSC-derived cell types include hepatocytes, neurons, cardiomyocytes, endothelial cells, and other cells like astrocytes, fibroblasts, and hematopoietic progenitor cells.

The BCC Research report assesses the current market status, future needs, and growth forecasts through 2028.

The report also analyzes market drivers, restraints, challenges and opportunities, and profiles the leading companies, including their business segments, financials, product portfolios, and recent developments. Additionally, it covers emerging technologies, new developments, the regulatory landscape, patent analysis, pipeline analysis, and investment outlook.

The factors driving the global market for induced pluripotent stem cells include:

Growing Prevalence of Chronic Diseases: iPSCs help develop new treatments for chronic conditions like diabetes and heart disease.

Increasing Investments in the Biotech Industry: Significant public and private investments are boosting iPSC research and innovation.

Surging Demand for Personalized Medicines: iPSCs enable personalized therapies tailored to individual genetic profiles.

Increasing Demand for Drug Discovery and Development: iPSCs facilitate drug discovery by creating disease models and testing new drugs.

Request a sample copy of the global market report for Induced Pluripotent Stem Cells .

Report Synopsis

Report Metric	Details
Base year considered	2023
Forecast period considered	2023-2028
Base year market size	$3.1 billion
Market size forecast	$5.2 billion
Growth rate	CAGR of 9.1% from 2023 to 2028
Segments covered	Reprogramming Method, Generation Method, Application, Product Function, iPSC-Derived Cell Type, Species, End Use, and Region
Regions covered	U.S., Europe, Asia-Pacific, and the Rest of the World (RoW)
Market drivers	Growing prevalence of chronic diseases. Increasing investments in the biotech industry. Surging demand for personalized medicines. Increasing demand for drug discovery and development.

Interesting Facts:

• Scientists use iPSC-derived cells to test medications for safety and effectiveness before human trials; iPSC-derived neurons help evaluate treatments for Alzheimer's disease and Parkinson's disease.

• iPSCs allow researchers to study disease mechanisms, aiding in discovering novel therapies and early cancer biomarkers.

• iPSC-based human organoids replicate organ structures and functions, enabling disease research and testing of new drugs and treatments.

Market Leaders include:

• NCARDIA
• QIAGEN
• REPROCELL INC.
• STEMCELL TECHNOLOGIES
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.
• ATCC
• AXOL BIOSCIENCE LTD.
• BIO-TECHNE
• FUJIFILM CELLULAR DYNAMICS INC.
• LONZA
• MERCK KGAA

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, please contact ....

About BCC Research

BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions, free of noise and hype.

CONTACT: Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA Email: ..., Phone: +1 781-489-7301 For media inquiries, email ... or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

MENAFN22012025004107003653ID1109118761